AMS - 2021-IMrh-Internal Medicine- Rheumatology

$119.00

5 AMA PRA Category 1 Credits™
$119.00
StreamingINCLUDED

Topics and Objectives

Title: IMrd-Internal Medicine- Radiology: Incidentalomas: Dealing With Unexpected Abnorma; Findings on Radiologic Exams; Contrast and Radiation Issues in Radiology: What a Clinician Should Know.
Ultrasound Basics.

Faculty: Adam R. Guttentag, M.D. Ryan K. Lee, M.D., M.B.A.

Original Release Date: July 1, 2021  Expiration Date: July 1, 2024

TOPIC 1: Incidentalomas: Dealing With Unexpected Abnormal Findings on Radiologic Exams.

Upon completion of this session, the participant should be able to: EBM, COMP

  1. Apply an evidence-based approach to determine the need for further evaluation of abnormalities found incidentally on imaging tests.
  2. Distinguish cystic renal masses that need imaging follow up from those that do not.
  3. Select appropriate further imaging when needed for small adrenal masses.

TOPIC 2: Contrast and Radiation Issues in Radiology: What a Clinician Should Know.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Utilize evidence based guidelines to appropriately order intravenous contrast for CT scans for patients with impaired renal function.
  2. Apply evidence based guidelines to decide whether it is safe to order intravenous contrast for MRI examinations.
  3. Describe factors leading to increased radiation exposure to patients from medical imaging.
  4. Select appropriate tests to order so as to minimize patient radiation dose without sacrificing diagnostic accuracy.

TOPIC 3: Ultrasound Basics.

Upon completion of this session, the participant should be able to: COMP  EBM GL

  1. Discuss commonly used terms in ultrasound.
  2. Determine in which clinical settings, based on the SRU Consensus Statement, ultrasound is the most appropriate study to order.
  3. Recognize US findings for common diseases/diagnoses.


Total Cost: $

Title: IMrh-Internal Medicine- Rheumatology: Osteoporosis; Scleroderma and Raynaud’s Disease; Rheumatoid Arthritis.

Faculty: Linda Brecher D.O., F.A.C.O.I., F.A.C.R., Lawrence Brent M.D.

Original Release Date: July 1, 2021  Expiration Date: July 1, 2024

TOPIC 1: Osteoporosis.

Upon completion of this session, the participant should be able to: GL, EBM, COMP

  1. Detect patients who are at risk for osteoporosis.
  2. Recognize the need for bone density testing as recommended by the International Society of Clinical Densitomethy and the National Osteoporosis Foundation guidelines.
  3. Differentiate the nonpharmacologic and pharmacologic treatments for osteoporosis as recommended by the National Osteoporosis Foundation guidelines.

TOPIC 2: Scleroderma and Raynaud’s Disease.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Specify the clinical manifestations of scleroderma.
  2. Apply the ACR/EULAR classification criteria for systemic sclerosis.
  3. Utilize treatment available for symptomatic manifestations as per the current EULAR recommendations.
  4. Apply the diagnostic work-up and treatment of Raynaud’s Phenomenon.

TOPIC 3: Rheumatoid Arthritis.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Demonstrate the role of genetics, environmental factors, immune cells, and proinflammatory cytokines in the pathogenesis of rheumatoid arthritis.
  2. Illustrate the clinical features, extra-articular manifestations, and complications of rheumatoid arthritis.
  3. Utilize and compare various methods of measuring disease activity in rheumatoid arthritis.
  4. Compare and contrast the mechanisms of action of current and emerging therapies for RA and prescribe treatment for patients with rheumatoid arthritis according to ACR guidelines.